ArticleFrontiers in genetics2021
Genomic and Chemical Diversity of Commercially Available High-CBD Industrial Hemp Accessions.
Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 23 citations in OpenAlex.
- Genetic Advances inPlants (Basel, Switzerland) · 2026Review
- Population Structure of Genotypes and Genome-Wide Association Studies of Cannabinoids and Terpenes Synthesis in Hemp (Plants (Basel, Switzerland) · 2026Article
- Genetic diversity, population structure, and cannabinoid variation in feral Cannabis sativa germplasm from the United States.Scientific reports · 2025Article
- Development and validation of a minimal SNP genotyping panel for the differentiation of Cannabis sativa cultivars.BMC genomics · 2025Article
- From fibers to flowering to metabolites: unlocking hemp (Cannabis sativa) potential with the guidance of novel discoveries and tools.Journal of experimental botany · 2025Review
- Potency and safety analysis of hemp delta-9 products: the hemp vs. cannabis demarcation problem.Journal of cannabis research · 2023Article
- The Desert Whale: the boom and bust of hemp in Arizona.Journal of cannabis research · 2023Article
- Oxylipin biosynthetic gene families of Cannabis sativa.PloS one · 2023Article
- Interpol Review of Drug Analysis 2019-2022.Forensic science international. Synergy · 2023Review
- Genome-Wide Identification and Expression Analysis of Wall-Associated Kinase (WAK) Gene Family inPlants (Basel, Switzerland) · 2022Article
- New Insight into Ornamental Applications of Cannabis: Perspectives and Challenges.Plants (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High consumer demand for cannabidiol (CBD) has made high-CBD hemp (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.